BMC Nephrology | |
Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH | |
Research Article | |
Yoshinaga Otaki1  Takeshi Nakanishi1  Mana Yahiro1  Aritoshi Kida1  Yukiko Hasuike1  Takahiro Kuragano2  Minoru Furuta3  Akihide Matsumoto3  | |
[1] Department of Internal Medicine Division of kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Japan;Department of Internal Medicine Division of kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Japan;Takahiro Kuragano, 1-1, Mukogawa cho, 663-8501, Nishinomiya, Japan;Seishoukai Aoi Hospital, Nishinomiya, Japan; | |
关键词: Acetate free citrate-containing dialysate; Low intact-parathyroid hormone; Bone alkaline phosphatase; Total calcium; Ionized calcium; | |
DOI : 10.1186/1471-2369-14-18 | |
received in 2012-05-07, accepted in 2013-01-11, 发布年份 2013 | |
来源: Springer | |
【 摘 要 】
BackgroundRecently, acetate-free citrate containing dialysate (A(−)D) was developed. We have already reported about the significant effect of A(−)D on metabolic acidosis, anemia, and malnutrition in maintenance hemodialysis (MHD) patients. In this study, we compared the effect of A(−)D and acetate containing dialysate (A(+)D) on serum calcium and intact-parathyroid hormone (int-PTH) levels.MethodSingle session study: Seventeen patients were treated with A(+)D in one session and also treated with A(−)D in another session. Serum levels of pH, HCO3-, total (t)-calcium, ionized (i)-calcium, and int-PTH were evaluated at the beginning and the end of each session. Cross over study: A total of 29 patients with MHD were treated with A(+)D for 4 months, switched to A(−)D for next 4 months, and returned to A(+)D for the final 4 months.ResultsIn single session study, serum i-calcium and t-calcium levels significantly increased, and int-PTH levels decreased after HD with A(+)D, whereas HD with A(−)D did not affect iCa and int-PTH. In cross over study, if all patients were analyzed, there was no significant difference in serum int-PTH or bone alkaline phosphatase (BAP) levels during each study period. In contrast, in the patients with low int-PTH (<60 pg/mL), serum levels of int-PTH and BAP were significantly increased during the A(−)D, without significant changes in serum t-calcium or i-calcium levels.ConclusionA(−)D containing citrate could affect calcium and PTH levels, and, in 4 month period of crossover study, increased int-PTH levels pararelled with increasing BAP levels, exclusively in MHD patients with low int-PTH levels.
【 授权许可】
CC BY
© Kuragano et al.; licensee BioMed Central Ltd. 2013
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311097062550ZK.pdf | 891KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]